(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

USOS TERAPÊUTICOS DE ANTAGONISTAS DE ANTÍGENO DE MATURAÇÃO DE CÉLULAS B

Em AnáliseInvention PatentPCT · IB2023062182

Application data

Number

112025010224

Type

Invention Patent

Filing

12/04/2023

Publication

12/23/2025

PCT

IB2023062182

Progress at the INPI

Examination not yet requested
  1. Filing12/04/23
  2. Publication
  3. Examination
  4. Allowance
  5. Grant
  6. In force

Examination has not been requested yet. Without that request by 12/04/2026, the application is definitively abandoned (art. 33 of the Brazilian IP Act).

Deadline to request examination:12/04/2026(101 days left)

Leave your contact and we will alert you

We track INPI publications and let you know as soon as this case moves.

We use your details only for this alert.

Latest action published by the INPI: 12/23/2025. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED

GB

See this company's full portfolio

Inventors

A. T. (pessoa física)

US

B. K. (pessoa física)

US

C. S. (pessoa física)

US

H. S. (pessoa física)

US

I. G. (pessoa física)

US

Technical data

Priority claims

US

63/430,249 · 12/05/2022

Abstract

USOS TERAPÊUTICOS DE ANTAGONISTAS DE ANTÍGENO DE MATURAÇÃO DE CÉLULAS B. A divulgação fornece métodos para tratamento de uma doença ou distúrbio responsivo à inibição ou bloqueio do antígeno de maturação de células B (BCMA) pela administração de um ou mais antagonistas de BCMA.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Notificação de entrada na fase nacional - PCT

#1.3

12/23/2025

RPI 2868

Alteração de dados cadastrais

#1.1

06/10/2025

RPI 2840

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.